Angiopoietin-like protein 4 inhibition of lipoprotein lipase: Evidence for reversible complex formation

Journal of Biological Chemistry

Volumn 288, Issue 40, 2013, Pages 28524-28534

  Lafferty, Michael J ^a   Bradford, Kira C ^b   Erie, Dorothy A ^b   Neher, Saskia B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEX FORMATIONS; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; MOLECULAR CHAPERONES;

BIOCHEMISTRY; BIOLOGY;

LIPOPROTEINS;

ANGIOPOIETIN LIKE PROTEIN 4; CHAPERONE; CHELATING AGENT; DIVALENT CATION; ENZYME INHIBITOR; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DISSOCIATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; HYPERTRIGLYCERIDEMIA; INTRACELLULAR SPACE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN UNFOLDING; REGULATORY MECHANISM; STOICHIOMETRY; TRIACYLGLYCEROL BLOOD LEVEL;

ANGIOPOIETIN-LIKE PROTEIN 4; ATOMIC FORCE MICROSCOPY; ENZYME INHIBITORS; ENZYME MECHANISMS; LIPASE; LIPID METABOLISM; LIPOPROTEIN LIPASE;

ANGIOPOIETINS; ANIMALS; BIOCATALYSIS; CATTLE; CHROMATOGRAPHY, AFFINITY; CROSS-LINKING REAGENTS; ENZYME ACTIVATION; HEPARIN; HOT TEMPERATURE; LIPOPROTEIN LIPASE; MICROSCOPY, ATOMIC FORCE; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; SEPHAROSE; TIME FACTORS;

EID: 84885101882     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.497602     Document Type: Article

References (49)

1. Mead, J. R., Irvine, S. A., and Ramji, D. P. (2002) Lipoprotein lipase: structure, function, regulation, and role in disease. J. Mol. Med. 80, 753-769
2. Johansen, C. T., and Hegele, R. A. (2011) Genetic bases of hypertriglyceridemic phenotypes. Curr. Opin. Lipidol. 22, 247-253
3. Nichols, G. A., Arondekar, B., and Garrison, L. P., Jr. (2011) Patient characteristics and medical care costs associated with hypertriglyceridemia. Am. J. Cardiol. 107, 225-229
4. Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., Lennie, T. A., Levi, M., Mazzone, T., and Pennathur, S. (2011) Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123, 2292-2333
5. D'Agostino, R. B., Jr., Hamman, R. F., Karter, A. J., Mykkanen, L., Wagenknecht, L. E., and Haffner, S. M. (2004) Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care 27, 2234-2240
6. Kersten, S. (2005) Regulation of lipid metabolism via angiopoietin-like proteins. Biochem. Soc. Trans. 33, 1059-1062
7. Gaudet, D., Méthot, J., Déry, S., Brisson, D., Essiembre, C., Tremblay, G., Tremblay, K., de Wal, J., Twisk, J., van den Bulk, N., Sier-Ferreira, V., and van Deventer, S. (2013) Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. Gene Ther. 20, 361-369
8. Wong, H., and Schotz, M. C. (2002) The lipase gene family. J. Lipid Res. 43, 993-999
9. Kobayashi, Y., Nakajima, T., and Inoue, I. (2002) Molecular modeling of the dimeric structure of human lipoprotein lipase and functional studies of the carboxyl-terminal domain. Eur. J. Biochem. 269, 4701-4710
10. Bourne, Y., Martinez, C., Kerfelec, B., Lombardo, D., Chapus, C., and Cambillau, C. (1994) Horse pancreatic lipase. The crystal structure refined at 2.3 A resolution. J. Mol. Biol. 238, 709-732
11. Gin, P., Goulbourne, C. N., Adeyo, O., Beigneux, A. P., Davies, B. S., Tat, S., Voss, C. V., Bensadoun, A., Fong, L. G., and Young, S. G. (2012) Chylomicronemia mutations yield new insights into interactions between lipoprotein lipase and GPIHBP1. Hum. Mol. Genet. 21, 2961-2972
12. Lookene, A., Zhang, L., Hultin, M., and Olivecrona, G. (2004) Rapid subunit exchange in dimeric lipoprotein lipase and properties of the inactive monomer. J. Biol. Chem. 279, 49964-49972
13. Wong, H., Yang, D., Hill, J. S., Davis, R. C., Nikazy, J., and Schotz, M. C. (1997) A molecular biology-based approach to resolve the subunit orientation of lipoprotein lipase. Proc. Natl. Acad. Sci. U.S.A. 94, 5594-5598
14. Ruge, T., Svensson, M., Eriksson, J. W., and Olivecrona, G. (2005) Tissuespecific regulation of lipoprotein lipase in humans: effects of fasting. Eur. J. Clin. Invest. 35, 194-200
15. Kersten, S., Mandard, S., Tan, N. S., Escher, P., Metzger, D., Chambon, P., Gonzalez, F. J., Desvergne, B., and Wahli, W. (2000) Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferatoractivated receptor target gene. J. Biol. Chem. 275, 28488-28493
16. Köster, A., Chao, Y. B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P. A., Hale, J. E., Li, D., Qiu, Y., Fraser, C. C., Yang, D. D., Heuer, J. G., Jaskunas, S. R., and Eacho, P. (2005) Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146, 4943-4950
17. Yoshida, K., Shimizugawa, T., Ono, M., and Furukawa, H. (2002) Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 43, 1770-1772
18. Ge, H., Yang, G., Huang, L., Motola, D. L., Pourbahrami, T., and Li, C. (2004) Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J. Biol. Chem. 279, 2038-2045
19. Lei, X., Shi, F., Basu, D., Huq, A., Routhier, S., Day, R., and Jin, W. (2011) Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity. J. Biol. Chem. 286, 15747-15756
20. Ge, H., Yang, G., Yu, X., Pourbahrami, T., and Li, C. (2004) Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J. Lipid Res. 45, 2071-2079
21. Yin, W., Romeo, S., Chang, S., Grishin, N. V., Hobbs, H. H., and Cohen, J. C. (2009) Genetic variation in ANGPTL4 provides insights into protein processing and function. J. Biol. Chem. 284, 13213-13222
22. Sukonina, V., Lookene, A., Olivecrona, T., and Olivecrona, G. (2006) Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl. Acad. Sci. U.S.A. 103, 17450-17455
23. Osborne, J. C., Jr., Bengtsson-Olivecrona, G., Lee, N. S., and Olivecrona, T. (1985) Studies on inactivation of lipoprotein lipase: role of the dimer to monomer dissociation. Biochemistry 24, 5606-5611
24. Robciuc, M. R., Tahvanainen, E., Jauhiainen, M., and Ehnholm, C. (2010) Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample. J. Lipid Res. 51, 824-831
25. Davies, B. S., Goulbourne, C. N., Barnes, R. H., 2nd, Turlo, K. A., Gin, P., Vaughan, S., Vaux, D. J., Bensadoun, A., Beigneux, A. P., Fong, L. G., and Young, S. G. (2012) Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells. J. Lipid Res. 53, 2690-2697
26. Bengtsson-Olivecrona, G., and Olivecrona, T. (1991) Phospholipase activity of milk lipoprotein lipase. Methods Enzymol. 197, 345-356
27. Shan, L., Yu, X. C., Liu, Z., Hu, Y., Sturgis, L. T., Miranda, M. L., and Liu, Q. (2009) The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J. Biol. Chem. 284, 1419-1424
28. Der, B. S., Machius, M., Miley, M. J., Mills, J. L., Szyperski, T., and Kuhlman, B. (2012) Metal-mediated affinity and orientation specificity in a computationally designed protein homodimer. J. Am. Chem. Soc. 134, 375-385
29. Ericsson, U. B., Hallberg, B. M., Detitta, G. T., Dekker, N., and Nordlund, P. (2006) Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal. Biochem. 357, 289-298
30. Ratcliff, G. C., and Erie, D. A. (2001) A novel single-molecule study to determine protein-protein association constants. J. Am. Chem. Soc. 123, 5632-5635
31. Yang, Y., Wang, H., and Erie, D. A. (2003) Quantitative characterization of biomolecular assemblies and interactions using atomic force microscopy. Methods 29, 175-187
32. Bengtsson, G., and Olivecrona, T. (1979) Binding of deoxycholate to lipoprotein lipase. Biochim. Biophys. Acta 575, 471-474
33. Pantoliano, M. W., Petrella, E. C., Kwasnoski, J. D., Lobanov, V. S., Myslik, J., Graf, E., Carver, T., Asel, E., Springer, B. A., Lane, P., and Salemme, F. R. (2001) High-density miniaturized thermal shift assays as a general strategy for drug discovery. J. Biomol. Screen. 6, 429-440
34. Peterson, J., Fujimoto, W. Y., and Brunzell, J. D. (1992) Human lipoprotein lipase: relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies. J. Lipid Res. 33, 1165-1170
35. Segel, I. H. (1975) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady State Enzyme Systems, pp. 125-135, John Wiley & Sons, Inc., New York
36. Lichtenstein, L., Berbée, J. F., van Dijk, S. J., van Dijk, K. W., Bensadoun, A., Kema, I. P., Voshol, P. J., Müller, M., Rensen, P. C., and Kersten, S. (2007) Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPLand HL-dependent hepatic cholesterol uptake. Arterioscler. Thromb. Vasc. Biol. 27, 2420-2427
37. Liberek, K., Lewandowska, A., and Zietkiewicz, S. (2008) Chaperones in control of protein disaggregation. EMBO J. 27, 328-335
38. Sonnenburg, W. K., Yu, D., Lee, E. C., Xiong, W., Gololobov, G., Key, B., Gay, J., Wilganowski, N., Hu, Y., Zhao, S., Schneider, M., Ding, Z. M., Zambrowicz, B. P., Landes, G., Powell, D. R., and Desai, U. (2009) GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4. J. Lipid Res. 50, 2421-2429
39. Arias, H. R., Bhumireddy, P., and Bouzat, C. (2006) Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors. Int. J. Biochem. Cell Biol. 38, 1254-1276
40. Wang, H., and Eckel, R. H. (2009) Lipoprotein lipase: from gene to obesity. Am. J. Physiol. Endocrinol. Metab. 297, E271-E288
41. Beigneux, A. P., Davies, B. S., Gin, P., Weinstein, M. M., Farber, E., Qiao, X., Peale, F., Bunting, S., Walzem, R. L., Wong, J. S., Blaner, W. S., Ding, Z. M., Melford, K., Wongsiriroj, N., Shu, X., de Sauvage, F., Ryan, R. O., Fong, L. G., Bensadoun, A., and Young, S. G. (2007) Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 5, 279-291
42. Davies, B. S., Beigneux, A. P., Barnes, R. H., 2nd, Tu, Y., Gin, P., Weinstein, M. M., Nobumori, C., Nyrén, R., Goldberg, I., Olivecrona, G., Bensadoun, A., Young, S. G., and Fong, L. G. (2010) GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab. 12, 42-52
43. Smart-Halajko, M. C., Robciuc, M. R., Cooper, J. A., Jauhiainen, M., Kumari, M., Kivimaki, M., Khaw, K. T., Boekholdt, S. M., Wareham, N. J., Gaunt, T. R., Day, I. N., Braund, P. S., Nelson, C. P., Hall, A. S., Samani, N. J., Humphries, S. E., Ehnholm, C., and Talmud, P. J. (2010) The relationship between plasma angiopoietin-like protein 4 levels, angiopoietinlike protein 4 genotype, and coronary heart disease risk. Arterioscler. Thromb. Vasc. Biol. 30, 2277-2282
44. Cazes, A., Galaup, A., Chomel, C., Bignon, M., Bréchot, N., Le Jan, S., Weber, H., Corvol, P., Muller, L., Germain, S., and Monnot, C. (2006) Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ. Res. 99, 1207-1215
45. Nilsson, S. K., Anderson, F., Ericsson, M., Larsson, M., Makoveichuk, E., Lookene, A., Heeren, J., and Olivecrona, G. (2012) Triacylglycerol-rich lipoproteins protect lipoprotein lipase from inactivation by ANGPTL3 and ANGPTL4. Biochim. Biophys. Acta 1821, 1370-1378
46. Robal, T., Larsson, M., Martin, M., Olivecrona, G., and Lookene, A. (2012) Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase. J. Biol. Chem. 287, 29739-29752
47. Lafontan, M., and Langin, D. (2009) Lipolysis and lipid mobilization in human adipose tissue. Prog. Lipid Res. 48, 275-297
48. Romeo, S., Pennacchio, L. A., Fu, Y., Boerwinkle, E., Tybjaerg-Hansen, A., Hobbs, H. H., and Cohen, J. C. (2007) Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat. Genet. 39, 513-516
49. Desai, U., Lee, E. C., Chung, K., Gao, C., Gay, J., Key, B., Hansen, G., Machajewski, D., Platt, K. A., Sands, A. T., Schneider, M., Van Sligtenhorst, I., Suwanichkul, A., Vogel, P., Wilganowski, N., Wingert, J., Zambrowicz, B. P., Landes, G., and Powell, D. R. (2007) Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice. Proc. Natl. Acad. Sci. U.S.A. 104, 11766-11771